Displaying 81 - 100 of 1636
FTC Staff Reaffirm Opposition to Proposed Indiana Hospital Merger
Date
Today, Federal Trade Commission staff again urged the Indiana Department of Health to deny Union Hospital, Inc. (Union Health) and Terre Haute Regional Hospital, L.P.’s (THRH) application to merge...
FTC Challenges Medical Device Coatings Deal
Date
The Federal Trade Commission today sued to block GTCR BC Holdings, LLC’s (GTCR) acquisition of Surmodics, Inc. (Surmodics), alleging that the deal, which seeks to combine the two largest manufacturers...
Federal Register Notice
Welsh, Carson, Anderson & Stowe; Analysis of Agreement Containing Consent Order To Aid Public Comment
Date
Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
241 0005
File
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Welsh, Carson, Anderson & Stowe
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak In the Matter of US Anesthesia Partners/Guardian Anesthesia
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Former Commissioner
Matter Number
201 0031
FTC Secures Settlement with Private Equity Firm in Antitrust Roll-Up Scheme Case
Date
The Federal Trade Commission today announced a settlement with private equity firm Welsh, Carson, Anderson, and Stowe and its affiliates (collectively referred to as “Welsh Carson”) that resolves a...
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Second Pharmacy Benefit Managers Interim Staff Report
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Former Commissioner
Matter Number
P221200
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
Date
The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty...
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Tuesday, January 14, 2025. The open meeting will commence at 11 a.m. ET...
FTC Announces Refund Claims Process for Consumers Who Bought Deceptively Marketed Golden Sunrise Nutraceutical Products
Date
The Federal Trade Commission is sending refund claim forms to consumers who bought deceptively marketed treatment plans sold by Golden Sunrise Nutraceutical, Inc., including products that falsely...
FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
Date
Today, the U.S. Court of Appeals for the Federal Circuit affirmed a lower district court order against pharmaceutical maker Teva requiring the drugmaker to delist several asthma inhaler patents from...
FTC Staff Sends Warning Letters to Healthcare Plan Marketers and Lead Generators
Date
As open enrollment season for healthcare plans is ongoing, the staff of the Federal Trade Commission is sending warning letters to 21 companies that market or generate sales leads for such plans...
Statement of Chair Lina M. Khan In the Matter of Cooperativa de Farmacias Puertoriqueñas
Date
By
Lina M. Khan, Former Chair and Commissioner
FTC Approves Modification of Cooperativa De Farmacias Puertorriqueñas Final Commission Order
Date
Following a public comment period, the Federal Trade Commission has approved a petition by Cooperativa De Farmacias Puertorriqueñas, a Puerto Rican cooperative of independent pharmacy owners, to...
Statement of Commissioner Melissa Holyoak In the Matter of Cooperativa De Farmacias Puertorriqueña
Date
By
Melissa Holyoak, Former Commissioner
Matter Number
C4374
Cooperativa de Farmacias Puertorriqueñas ("Coopharma")
A Puerto Rican cooperative of pharmacy owners, Cooperativa de Farmacias Puertorriqueñas, known as "Coopharma," agreed to settle Federal Trade Commission charges that it harmed competition by negotiating, entering into, and implementing agreements among its member pharmacies to fix prices on which they contract with insurers and pharmacy benefit managers. In settling the charges, Coopharma has agreed not to engage in such conduct in the future. Following a public comment period, the Federal Trade Commission has approved a petition by Cooperativa De Farmacias Puertorriqueñas, a Puerto Rican cooperative of independent pharmacy owners, to reopen and modify the FTC’s 2012 final order.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
101 0079
C-4374
SuperGoodDeals.com, Inc.
The FTC filed a complaint against SuperGoodDeals.com, Inc. and its owner, Kevin J. Lipsitz, alleging that the defendants falsely promised consumers next-day shipping of facemasks and other personal protective equipment (PPE) to deal with the coronavirus pandemic. In addition, the FTC alleged that some of the other merchandise sold through the SuperGoodDeals website were falsely advertised as “authentic” or “certified.”
Kevin Lipsitz, who defrauded consumers by falsely promising “next day” shipping of facemasks and respirators to consumers at the height of the COVID-19 pandemic, will be banned from selling personal protective equipment (PPE) and be required to turn over more than $145,000 to the FTC.
In December 2024, the FTC sent more than $114,000 to consumers who were deceived by “next day shipping” claims on badly needed personal protective equipment (PPE) by online seller SuperGoodDeals.com.
Type of Action
Federal
Last Updated
FTC Matter/File Number
202 3135
Case Status
Pending
Displaying 81 - 100 of 1636